Aug 8, 2019: UPS yesterday announced that its services for pharmaceutical shipping in Germany are now Good Distribution Practice (GDP)-certified.
This certificated granted by Deutsche Gesellschaft zur Zertifizierung von Managementsystemen (DQS), means that the UPS network is suitable for shipping not only pharmaceuticals but also medical devices (implants, diagnostics and medical imaging), diagnostic products (including reagents), stable blood products, and cosmetics.
With this, UPS also meets the standards set by the European Union for the shipment of non-temperature controlled healthcare products for human use.
“Healthcare packages containing pharmaceuticals or medical devices often require the highest standards for handling and transport—there is often so much more at stake than a typical package,” said Frank Sportolari, president, UPS Germany.
The EU’s healthcare-product distribution standards are set by the European Medicines Agency, describing the conditions that a wholesale distributor must meet to ensure that the quality and integrity of medicines are maintained throughout the supply chain journey.
Following an audit, UPS’s existing GDP-compliant procedures across its entire German network were certified to meet the specific requirements of the European Commission guideline 2013/C 343/01 for the non-temperature controlled transport of pharmaceutical products.
GDP certification is based on a range of assessment criteria, including quality control, employee training, safety, internal inspection procedures, and facility cleanliness.
Particularly for pharmaceutical and biopharmaceutical manufacturers, as well as for medical drug retailers, this certification is an endorsement of existing high standards throughout the supply chain that can reduce administration and simplify risk assessment processes when shipping with UPS.
UPS has a network of 14 dedicated healthcare logistics facilities across Europe with 600,000 square meters of warehouse space.